CG Oncology (NASDAQ:CGON) Stock Quotes, Forecast and News Summary

Q: What sector and industry does CG Oncology (CGON) operate in?

CG Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CG Oncology Stock (NASDAQ: CGON) stock price, news, charts, stock research, profile.

Open	$27.58
Close	$28.67
Volume / Avg.	1.47M / 717.52K
Day Range	$27.58 - $28.94
52 Wk Range	25.77 - 50.23
Market Cap	$2.18B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	6.98%
Days to Cover	11.36

Recent News

Why CG Oncology (CGON) Stock Is Down 9%

CG Oncology shares are trading lower by 9.2% during Wednesday's session. The company announced it filed an underwritten public offering of 7.3 million shares of its common stock.

Henry Khederian

CG Oncology Touts Encouraging Data From Late-Stage Study Of Bladder Cancer Candidate

CG Oncology's BOND-003 trial reveals durable efficacy of cretostimogene in NMIBC patients, with median DOR exceeding 27 months and no severe side effects.

Vandana Singh

Discover the 3 Best-Performing Biotech IPO Stocks of 2024

Biotech and pharmaceutical companies are well known for raising capital through initial public offerings, or IPOs. Between 2001 and 2023, approximately 24% of IPOs were from biotech and pharmaceutical companies. When

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep

Oct

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$27.58
Close	$28.67
Volume / Avg.	1.47M / 717.52K
Day Range	$27.58 - $28.94
52 Wk Range	25.77 - 50.23
Market Cap	$2.18B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	6.98%
Days to Cover	11.36

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy CG Oncology (CGON) stock?

You can purchase shares of CG Oncology (NASDAQ:CGON) through any online brokerage.

View our list of the best stock brokerages

Who are CG Oncology (CGON) competitors?

Other companies in CG Oncology’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Centessa Pharmaceuticals (NASDAQ:CNTA), Arcutis Biotherapeutics (NASDAQ:ARQT), Xencor (NASDAQ:XNCR) and SpringWorks Therapeutics (NASDAQ:SWTX).

What is the forecast, or price target, for CG Oncology (CGON) stock?

CG Oncology has a consensus price target of $63.88.

What is the current price for CG Oncology (CGON)?

The stock price for CG Oncology (NASDAQ: CGON) is $28.6705 last updated December 20, 2024 at 4:01 PM EST.

Does CG Oncology (CGON) pay a dividend?

There are no upcoming dividends for CG Oncology.

When is CG Oncology (NASDAQ:CGON) reporting earnings?

CG Oncology’s Q4 earnings are confirmed for Sunday, February 2, 2025.

Is CG Oncology (CGON) going to split?

There is no upcoming split for CG Oncology.

What sector and industry does CG Oncology (CGON) operate in?

CG Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

CG Oncology

CG Oncology (CGON) Forecast